RI
SOPH icon

RTW Investments’s SOPHiA GENETICS SOPH Stock Holding History

RTW Investments’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-226,589
Closed -$1.75M – 114
2022
Q1 		$1.75M Sell
226,589
-73,411
-24% -$825K 0.04% 91
2021
Q4 		$4.23M Hold
300,000
– – 0.06% 99
2021
Q3 		$5.26M Buy
+300,000
New +$5.28M 0.08% 91

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments's SOPH Position: Q2 2022 in Review

RTW Investments sold out of SOPHiA GENETICS (SOPH) in Q2 2022, closing a stake of 226,589 shares — an estimated $1.75M sold.

RTW Investments first reported a position in SOPH in Q3 2021 and held it in 3 quarters. The position peaked at $5.26M in Q3 2021. 34 funds tracked by Wall St. Rank hold SOPH as of Q2 2022.

  • RTW Investments reported no remaining SOPHiA GENETICS position as of Q2 2022 after selling out during the quarter.
  • RTW Investments sold 226,589 SOPHiA GENETICS shares in Q2 2022, an estimated $1.75M.
  • RTW Investments first reported a position in SOPHiA GENETICS in Q3 2021 and held it in 3 quarters.
  • RTW Investments's SOPHiA GENETICS position peaked at $5.26M in Q3 2021.
  • 34 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2022.

Based on RTW Investments's 13F filing for Q2 2022, filed 15 Aug 2022.